About
Small Molecule Brain Disease Therapeutic
Areas of Focus
Categories
Small Molecule Pharmaceutical
Team (30)
Clinical Trials (2)
View allTotal Trials
2
As Lead Sponsor
2
As Collaborator
0
Total Enrollment
222
By Phase
PHASE2: 1PHASE1: 1
By Status
RECRUITING: 1COMPLETED: 1
Clinical Trials Pipeline2 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2022
2023
2024
2025
2026
2027
Today
Hover over trial bars to see details
Recent Trials
NCT07191483Lead Sponsor
A Study to Evaluate KYN-5356 in Adults With Cognitive Impairment Associated With Schizophrenia
PHASE2Recruiting
150 participants
Started: Aug 27, 2025 · Completed: Dec 31, 2026
NCT06225115Lead Sponsor
A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of KYN-5356 in Healthy Subjects Aged 18 to 55 Years
PHASE1Completed
72 participants
Started: Dec 21, 2023 · Completed: Oct 7, 2024
Locations (1)
Headquarters
Naarden, Netherlands
Map
Loading map...